David R. Epstein - 30 Jun 2021 Form 4 Insider Report for Evelo Biosciences, Inc.

Role
Director
Signature
/s/ Daniel S. Char, Attorney-in-Fact for David R. Epstein
Issuer symbol
EVLO on OTC
Transactions as of
30 Jun 2021
Net transactions value
$0
Form type
4
Filing time
02 Jul 2021, 16:25:48 UTC
Previous filing
21 Jun 2021
Next filing
20 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Restricted Stock Units Award $0 +24,629 $0.000000 24,629 30 Jun 2021 Common Stock 24,629 $0.000000 Direct F1
transaction EVLO Restricted Stock Units Award $0 +34,480 $0.000000 34,480 30 Jun 2021 Common Stock 34,480 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units will vest in 12 substantially equal monthly installment following the grant date, subject to the reporting person's continued service as chair of the board of directors of the issuer on such vesting dates.
F2 The restricted stock units will vest in 12 substantially equal monthly installment following the grant date, subject to the reporting person's continued service as a consultant to the issuer on such vesting dates.